NCT00189943

Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

Phase I Study on Safety, Tolerability and Immunogenicity of the MVA-BN Vaccine Administered to Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 90 (planned)
• Sponsor: Bavarian Nordic · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to collect information on the safety, tolerability and immunogenicity of an investigational smallpox vaccine at different doses and using different routes of administration in vaccinia-naive and vaccinated healthy volunteers

Conditions

• Smallpox

Interventions

Type	Name	Description
BIOLOGICAL	MVA-BN

Timeline

• Start date: 2001-04-01
• Completion: 2003-07-01
• First posted: 2005-09-19
• Last updated: 2005-09-19

Locations

1 site across 1 country: Germany